Biosimilars Market is Projected to Reach an Estimate of $143.6 Billion by 2031, with CAGR of 24.7% : Allied Market Research
The growth of the global biosimilars market is driven by the incidence of various types of cancers, including lung, blood, and brain tumors, which has increased significantly, and an increase in the incidence of autoimmune conditions such as ankylosing spondylitis and rheumatoid arthritis.Wilmington, Delaware, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Allied Market Research released a report, titled, “Biosimilars Market by Type (Erythropoietin, Human growth hormone, Monoclonal antibodies, Granulocyte-Co
Source: yahoo.com